[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360659-105":59,"doc-detail-360659-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","phosphatases-of-regenerating-liver-downregulate-pten-to-promote-tumorigenesis","Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis","","Review article synthesizing how phosphatases of regenerating liver (PRLs: PRL1, PRL2, PRL3) suppress the tumor suppressor PTEN and thereby promote tumorigenesis. The document explains PTEN downregulation via post-translational dephosphorylation of PTEN at Tyr336, leading to ubiquitination and proteasomal degradation, and via post-translational modulation of JAK2 by dephosphorylating Tyr570 to stimulate JAK2/STAT3-dependent miR-21 expression. It evaluates PRL structure, evolution, functional diversity, evidence linking PRLs to PTEN regulation, context-dependent PRL functions, unresolved catalytic-versus-scaffold questions, and therapeutic prospects for targeting the PRL–PTEN axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/phosphatases-of-regenerating-liver-downregulate-pten-to-promote-tumorigenesis/360659/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/phosphatases-of-regenerating-liver-downregulate-pten-to-promote-tumorigenesis/360659.png","ImageObject",300,407,{"name":92,"@type":93},"4398046744996","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do PRLs downregulate PTEN according to the review?","Question",{"text":112,"@type":113},"PRLs promote PTEN suppression through a post-translational mechanism by dephosphorylating PTEN at Tyr336, which facilitates PTEN ubiquitination and proteasomal degradation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What alternative mechanism links PRLs to PTEN-related signaling?",{"text":117,"@type":113},"PRLs can reduce PTEN expression by dephosphorylating the inhibitory Tyr570 in JAK2, thereby activating JAK2/STAT3-mediated miR-21 expression.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are PRLs considered potentially important therapeutic targets?",{"text":121,"@type":113},"PRL expression is frequently elevated in cancers and correlates with metastatic progression and poor clinical outcomes; targeting the PRL–PTEN axis could restore tumor suppressor function in PTEN-deficient cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360659,1790304700,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":66,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":36,"preview_page_count":19,"preview_urls":144},4398046744996,"Biochemical Society Transactions (2026) 54 845–860 [https://doi.org/10.1042/BST20250538](https://doi.org/10.1042/BST20250538)  \nReview Article  \nPhosphatases of regenerating liver downregulate PTEN to promote tumorigenesis  \n Ahmed M. Abou-Shanab1,2 ,  Jingmei Yu1 ,  Yunpeng Bai1 and  Zhong-Yin Zhang1,2,3,4  \n1 Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, U.S.A. ; 2 Institute for Cancer Research, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, U.S.A. ; 3James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, U.S.A. ; 4 Institute for Drug Discovery, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, U.S.A.  \nCorrespondence: Zhong-Yin Zhang ([zhang-zy@purdue.edu](zhang-zy@purdue.edu))  \nReceived: 27 April 2026  \nRevised: 15 June 2026  \nAccepted: 17 June 2026  \nVersion of Record published:  \n25 June 2026  \nThe phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the most frequently inactivated tumor suppressors in human cancers, serving as a critical negative regulator of phosphatidylinositol 3-kinase (PI3K)–AKT signaling. Although genetic mutation or deletion commonly underlie functional PTEN loss, accumulating evidence indicates that post-transcriptional and post-translational mechanisms also substantially contribute to PTEN suppression. Phosphatases of regenerating liver (PRLs), comprising PRL1, PRL2, and PRL3, are oncogenic phosphatases frequently overexpressed in both solid and hematological malignancies. Emerging studies reveal that PRLs can downregulate PTEN through a post-translational mechanism by direct dephosphorylation of PTEN at Tyr336, therefore promoting PTEN ubiquitination and proteasomal degradation. PRLs can also reduce PTEN expression through a post-transcriptional mechanism by dephosphorylating the inhibitory Tyr570 in JAK2, thereby activating the  \nJAK2/STAT3-mediated miR-21 expression. These coordinated actions collectively amplify PI3K–AKT signaling, consequently promoting proliferation, survival, and metastasis. In the present review, we synthesize current knowledge of PRL structure, evolution, and functional diversity, evaluate genetic, biochemical, and organismal evidence linking PRLs to PTEN regulation, and discuss insights on PRL oncogenicity derived from experimental models. We further examine context-dependent functions of PRLs, unresolved questions regarding catalytic versus scaffold activities, and the therapeutic potential of targeting the PRL–PTEN axis. Understanding how PRLs modulate PTEN activity may reveal new strategies to restore tumor suppressor function in PTEN-deficient cancers.  \nIntroduction  \nProtein tyrosine phosphorylation is a fundamental post-translational regulatory mechanism governing signaling pathways that control numerous cellular processes [1,2] . Cellular homeostasis depends on the tightly coordinated and reversible actions of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), which together maintain appropriate protein tyrosine phosphorylation levels and dynamics [3] . The human PTP superfamily comprises over 100 members, and dysregulation of PTP activity has been implicated in a wide range of pathologies, including cancer, metabolic disorders, and autoimmune diseases [4,5] . Within this superfamily, phosphatases of regenerating liver (PRLs), PRL1, PRL2, and PRL3, encoded by PTP4A1, PTP4A2, and PTP4A3, form a highly conserved subfamily sharing more than75% amino acid sequence identity [6,7] . By opposing the actions of PTKs, PTPs are often regarded as negative regulators of cell signaling and are thus long thought to be products of tumor suppressor genes. Recent findings, however, have overturned this narrative, firmly establishing many PTPs, including PRLs, PTP1B, and SHP2, as oncogenic drivers [8–10] . Interestingly, PRL expressions are upregulated in n","cbCaisKbbR9fnmvL","https://ap.wps.com/l/cbCaisKbbR9fnmvL","pdf",1319772,16,"English","# Introduction\n## Protein tyrosine phosphorylation and PTP regulation\n## PRL family features and oncogenic reclassification\n## PRL overexpression in cancers and signaling pathways\n## Knowledge gaps: substrates and catalytic vs scaffold roles","[{\"question\":\"How do PRLs downregulate PTEN according to the review?\",\"answer\":\"PRLs promote PTEN suppression through a post-translational mechanism by dephosphorylating PTEN at Tyr336, which facilitates PTEN ubiquitination and proteasomal degradation.\"},{\"question\":\"What alternative mechanism links PRLs to PTEN-related signaling?\",\"answer\":\"PRLs can reduce PTEN expression by dephosphorylating the inhibitory Tyr570 in JAK2, thereby activating JAK2/STAT3-mediated miR-21 expression.\"},{\"question\":\"Why are PRLs considered potentially important therapeutic targets?\",\"answer\":\"PRL expression is frequently elevated in cancers and correlates with metastatic progression and poor clinical outcomes; targeting the PRL–PTEN axis could restore tumor suppressor function in PTEN-deficient cancers.\"}]","Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis | PDF",1790140951,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1b12e74502a706a850eed6d865d2fb1.webp",983,1301,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86c289be9f0bad4a3a631488f86f0400.webp",982,1299,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e25d3d5fe426b23fea75ee6abfe60263.webp",981,1298,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb87e9013c0464479937d245a5ab9129.webp",980,1297]